Cellectis to Report Second Quarter 2022 Financial Results
Published on July 28, 2022 in New York, NY
July 28, 2022 - New York, NY –– Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the second quarter ended June 30th, 2022, on Thursday, August 4th, 2022, after the close of the US market.
The announcement will be followed by a conference call and webcast on Friday, August 5th, 2022, at 8:00 AM EDT / 2:00 PM CET. The call will include the Company’s second quarter results and an update on business activities. Details for the call are as follows:
Friday, August 5th at 8:00 am Eastern Time:
Conference ID: 13731385